Carregant...
Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine
BACKGROUND: Ranitidine (Zantac(®)) is a H(2)-receptor antagonist commonly used for the treatment of acid-related gastrointestinal diseases. Ranitidine was reported to be a substrate of the organic cation transporters OCT1 and OCT2. The hepatic transporter OCT1 is highly genetically variable. Twelve...
Guardat en:
| Publicat a: | PLoS One |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728534/ https://ncbi.nlm.nih.gov/pubmed/29236753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0189521 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|